Natural history of human T-lymphotropic virus 1–associated myelopathy: a 14-year follow-up study

S Olindo, P Cabre, A Lézin, H Merle… - Archives of …, 2006 - jamanetwork.com
Background The progression of neurological disability in human T-lymphotropic virus 1
(HTLV-1)–associated myelopathy/tropical spastic paraparesis (HAM/TSP) remains …

[PDF][PDF] HTLV-1 associated neurological complex. What is hidden below the water?

AQC Araujo, D Wedemann - Aids Reviews, 2019 - researchgate.net
The human T-cell lymphotropic virus type 1 (HTLV-1) infects 5-10 million people worldwide
and causes fatal and disabling diseases in a significant proportion of them. A chronic …

[HTML][HTML] An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) focusing on clinical and laboratory …

J Yamauchi, N Araya, N Yagishita, T Sato… - Pharmacology & …, 2021 - Elsevier
Human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is a rare inflammatory disease causing unremitting and progressive …

The peripheral nervous system complications of HTLV-1 myelopathy (HAM/TSP) syndromes

P Grindstaff, G Gruener - Seminars in neurology, 2005 - thieme-connect.com
Human T-cell lymphotropic virus type I (HTLV-1) is a human retrovirus and the etiologic
agent for a progressive neurological disease called HTLV-1-associated myelopathy/tropical …

Mediators of central nervous system damage during the progression of human T-cell leukemia type I-associated myelopathy/tropical spastic paraparesis

K Barmak, EW Harhaj, B Wigdahl - Journal of neurovirology, 2003 - Springer
Human T-cell leukemia virus type I (HTLV-I)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) represents one of the most devastating diseases associated with …

Neurological manifestations in human T-cell lymphotropic virus type 1 (HTLV-1)–infected individuals without HTLV-1–associated myelopathy/tropical spastic …

D Tanajura, N Castro, P Oliveira, A Neto… - Clinical infectious …, 2015 - academic.oup.com
Background. Human T-cell lymphotropic virus type 1 (HTLV-1) is the agent of HTLV-1–
associated myelopathy/tropical spastic paraparesis (HAM/TSP), observed in up to 5% of …

A new hypothesis for the pathogenesis of Human T-lymphotropic virus type 1 associated myelopathy/tropical spastic paraparesis

AJ Mosley, CRM Bangham - Bioscience Hypotheses, 2009 - Elsevier
The exogenous, human retrovirus Human T-lymphotropic virus type 1 (HTLV-1) results in a
highly dynamic persistent infection. HTLV-1 usually causes an asymptomatic infection but a …

Interferon Beta‐1a Improves Urinary Symptoms, Reduces Proviral Load, and Modifies the Immune Response in a Patient with HAM/TSP

DT Costa, M Sundberg, L Passos… - Case Reports in …, 2012 - Wiley Online Library
The human T‐cell lymphotropic virus type 1 (HTLV‐1) is the known causative agent of a
chronic neurologic condition known as HTLV‐1‐associated myelopathy/tropical spastic …

Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects

A Gessain, R Mahieux - Revue neurologique, 2012 - Elsevier
In 1980, HumanT cell leukemia/lymphoma virus type 1 (HTLV-1) was the first oncogenic
human retrovirus to be discovered. HTLV-1 belongs to the Retroviridae family, the …

Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP)

T Nakamura, Y Nishiura… - Central Nervous System …, 2009 - ingentaconnect.com
Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is chronic progressive myelopathy characterized by bilateral …